StockNews.com lowered shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a hold rating to a sell rating in a research report report published on Thursday. A number of other equities analysts have also issued reports on the stock. JMP Securities upped their target price on shares of Ocular Therapeutix from $11.00 to $12.00 in […]
Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its price objective increased by JMP Securities from $11.00 to $12.00 in a report issued on Tuesday, The Fly reports. A number of other equities research analysts have also commented on OCUL. HC Wainwright reaffirmed a buy rating and set a $11.00 price target on shares of Ocular […]
Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its price objective increased by JMP Securities from $11.00 to $12.00 in a research note published on Tuesday morning, The Fly reports. A number of other equities analysts have also weighed in on the stock. Robert W. Baird assumed coverage on shares of Ocular Therapeutix in a report […]
StockNews.com downgraded shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Thursday. A number of other brokerages also recently weighed in on OCUL. JMP Securities boosted their target price on shares of Ocular Therapeutix from $11.00 to $12.00 in a […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Rating) – HC Wainwright reduced their Q2 2023 earnings estimates for shares of Ocular Therapeutix in a research note issued on Tuesday, May 9th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.30) per share for the quarter, down from their prior forecast of […]